3

FORM 3 SUBMISSION

Company: CUMBERLAND PHARMACEUTICALS INC
Filed: October 18, 2011
Period of Report: October 18, 2011
Accession Number: 0001209191-11-051989

View Document ↗ View on SEC.gov ↗